VCE-003
/ Emerald Health Research, Aphios
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 14, 2012
A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis
(J Neuroimmune Pharmacol)
- VCE-003 (cannabigerol quinone) ameliorated the symptoms associated to TMEV infection, decreased microglia reactivity and modulated the expression of genes involved in MS pathophysiology; The data shows VCE-003 have high potential for drug development against MS and perhaps other neuroinflammatory diseases
New molecule • Multiple Sclerosis
1 to 1
Of
1
Go to page
1